Copyright
©The Author(s) 2017.
World J Cardiol. Feb 26, 2017; 9(2): 139-146
Published online Feb 26, 2017. doi: 10.4330/wjc.v9.i2.139
Published online Feb 26, 2017. doi: 10.4330/wjc.v9.i2.139
Table 2 Summary of data for left atrial appendage occlusion
PROTECT-AF[46] | CAP[43] | ASAP[42] | EWOLUTION[49] | ACP[50] | |
Patients (n) | 463 | 460 | 150 | 1021 | 1047 |
Follow-up | 4 yr | 16 mo | 14 mo | 30 d | 13 mo |
CHADS-score | 2.2 | 2.4 | 2.8 | 2.8 | n.a. |
CHA2DS2-Vasc score | n.a. | n.a. | 4.4 | 4.5 | 4.5 |
Procedural success | 88.00% | 95.00% | 94.70% | 98.50% | 97.30% |
Procedural stroke | 1.30% | 0 | 0.70% | n.a. | 0.90% |
Pericardial effusion | 4.80% | 2.20% | 1.30% | 0.50% | 1.20% |
Device embolization | 0.60% | 0 | 1.30% | 0.20% | n.a. |
Major bleeding | 3.50% | n.a. | n.a. | 1.60% | 1.50% |
Long-term stroke | 2.30% | 1.50% | 0.70% | 0.30% | 2.30% |
- Citation: Akin I, Nienaber CA. Left atrial appendage occlusion: A better alternative to anticoagulation? World J Cardiol 2017; 9(2): 139-146
- URL: https://www.wjgnet.com/1949-8462/full/v9/i2/139.htm
- DOI: https://dx.doi.org/10.4330/wjc.v9.i2.139